• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Heart Pump Devices Market Trends

    ID: MRFR/MED/4576-HCR
    100 Pages
    Kinjoll Dey
    October 2025

    Heart Pump Devices Market Research Report Information, By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, And Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, and Extracorpo...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Heart Pump Devices Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Heart Pump Devices Market

    In the recent years the market for heart pumps has been really in trend and this is due to the advancements that have been made in medical science and the higher prevalence of the diseases of the heart. The surge in VADs uptake presents one of the major recent trends as an alternative to surgical transplantation. These devices been known to be the most effective devices that offer the quality of life for patients waiting to be included in the list in for heart transplantation or those ineligible for transplantation. The market nowadays witnesses a growth in the demand of both intracorporeal and extra corporeal ventricle assist devices and giving users, the flexibility to choose among available options for their medical needs.

    Technological innovations are critically important in the evolution of market patterns, in where the continuous efforts being made to enhance device performance and minimized invasiveness are constantly being pursued and improved. The requirement for the miniaturization of heart pumps has now become very demanding, which in turn leads to smaller devices, and therefore, procedures with little or no injury to patients and lower risk of complications. Many new materials and better designs have improved the life span of pumps by making them more durable and dependable. Thus, the heart pumps become more efficient and people live longer. Therefore, healthcare professionals are now incorporating technologies in an increased rate to enable them to offer more innovative treatments for patients who are suffering from heart failure that is already advanced.

    A new trend (the destination therapy) in the implantable heart devices market is the given long term solution for patients with no transplant options to follow. VADs (ventricular assist devices) as destination therapy it always enables the patients to have active and improved living with their cardiac problems. This situation indicates the shift in the attitude of a ventricular assist devices from an emergency solution for a short period of time to a permanent one, liberating patients who might have otherwise no other choices.

    Additionally, a collaboration and partnership between the vital participants in the industry would be seen as the major market trend recently. This co-operative approach intends to mobilize the accumulated competitiveness as well as the resources of the different stakeholders, for example, those working in the area of medical devices, healthcare providers and the scientific institutions. Collaboration, which is seen as a key driver, allows the cardiovascular industry and other stakeholders to develop the solutions that address the diverse and systemic problems related to cardiovascular diseases and thus deliver better treatment outcomes for patients.

    Another market trend which is worth noting is the customer experience that consists of heightened awareness and use of digital means for the management of patients powered with heart pumps. These mechanics therefore correspond with the general movement in the sphere of digital health and patient-oriented care, and contribute to improvement of the situation in terms of patient experience and their adherence to therapies.

    Market Summary

    The Global Heart Pump Devices Market is projected to experience substantial growth from 0.74 USD Billion in 2024 to 6.31 USD Billion by 2035.

    Key Market Trends & Highlights

    Heart Pump Devices Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 20.2% from 2025 to 2034.
    • By 2035, the market valuation is anticipated to reach 5.6 USD Billion, reflecting a significant increase from the base year.
    • in 2024, the market is valued at 0.74 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of heart pump devices due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.74 (USD Billion)
    2035 Market Size 6.31 (USD Billion)
    CAGR (2025-2035) 21.50%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Medtronic, Abbott Laboratories, Abiomed, Getinge, Syncardia Systems, Teleflex, Reliantheart, Terumo, Berlin Heart, Jarvik Heart, Cardiacassist, Fresenius Medical Care, Thoratec Corporation

    Market Trends

    The rising tendency of heart diseases is driving the market growth

    Market CAGR for heart pump devices is being driven by the rise in heart-related diseases and technological updates. The spread of cardiovascular disorders is rising, which is driving demand for heart pump devices worldwide. Thousands of people affected by cardiovascular diseases (CVDs), a major reason of morbidity and mortality worldwide, include many medical illnesses such as heart failure, coronary artery disease, and cardiomyopathy. As the world's population ages and sedentary lifestyles grow more common, the incidence of CVDs is predicted to rise quickly, driving demand for innovative therapies and technologies like heart pump devices.

    A deeper understanding of heart disease and advancements in medical technology have also led to earlier and more frequent diagnoses, which has raised the demand for heart pump devices.

    Additional factors influencing the growth of the heart pump device market include the rising availability of reimbursement for these devices and improvements in device design and manufacturing that have boosted safety and efficacy. The World Health Organization (WHO) reported that cardiovascular illnesses are the main reason of mortality worldwide, taking an estimated 17.9 million lives annually. Heart attacks & strokes account for four out of every five deaths from cardiovascular illnesses. As a result, the market for heart pump devices is always growing.

    Additionally, the worldwide aging population is a significant factor driving the market for heart pump devices. The market's businesses are working to improve the effectiveness and dependability of cardiac plant devices by creating fresh goods. Additionally, there is a great need for Heart Pump Devices due to the shortage of heart donors. The  Heart Pump Devices Market will have a positive growth trend as a result of all these factors. Thus, driving the Heart Pump Devices Market revenue.

    The ongoing advancements in heart pump technologies are poised to enhance patient outcomes and expand treatment options for those with severe heart conditions.

    U.S. Food and Drug Administration (FDA)

    Heart Pump Devices Market Market Drivers

    Market Growth Projections

    The Global Heart Pump Devices Market Industry is projected to experience substantial growth over the coming years. With a market value of 0.74 USD Billion in 2024, it is anticipated to reach 5.6 USD Billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 20.2% from 2025 to 2035. This growth trajectory indicates a strong demand for heart pump devices, driven by factors such as technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures. The market's expansion is indicative of the critical role these devices play in modern cardiovascular care.

    Rising Healthcare Expenditure

    Global healthcare expenditure is on the rise, which positively impacts the Global Heart Pump Devices Market Industry. Increased funding allows for the adoption of advanced medical technologies, including heart pump devices, as healthcare systems strive to improve patient care. With a projected compound annual growth rate (CAGR) of 20.2% from 2025 to 2035, the market is poised for substantial growth. This financial commitment from governments and private sectors facilitates research and development, leading to innovative solutions that address the growing burden of cardiovascular diseases.

    Increasing Geriatric Population

    The aging population worldwide is a significant factor contributing to the growth of the Global Heart Pump Devices Market Industry. As individuals age, the risk of developing cardiovascular diseases increases, leading to a higher demand for heart pump devices. By 2035, the market is anticipated to expand significantly, driven by the needs of this demographic. The geriatric population often requires specialized care, and heart pump devices provide essential support for managing chronic heart conditions. This demographic shift underscores the necessity for healthcare systems to adapt and invest in advanced heart pump technologies.

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Heart Pump Devices Market Industry. As heart-related ailments continue to escalate, the demand for effective treatment options, including heart pump devices, rises correspondingly. With projections indicating that the market will reach 0.74 USD Billion in 2024, healthcare providers are compelled to adopt advanced technologies to manage these conditions. This trend is likely to persist, as cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, necessitating innovative solutions to improve patient outcomes.

    Growing Awareness and Education on Heart Health

    There is a notable increase in awareness and education regarding heart health, which drives the Global Heart Pump Devices Market Industry. Public health campaigns and educational initiatives are informing individuals about the risks associated with cardiovascular diseases and the available treatment options. As patients become more informed, they are more likely to seek medical intervention, including the use of heart pump devices. This heightened awareness is expected to contribute to the market's growth, as more individuals recognize the importance of early diagnosis and treatment in managing heart conditions.

    Technological Advancements in Heart Pump Devices

    Technological innovations play a crucial role in shaping the Global Heart Pump Devices Market Industry. The development of miniaturized, more efficient, and biocompatible devices enhances patient comfort and outcomes. For instance, advancements in ventricular assist devices (VADs) have significantly improved their functionality and reliability. As these technologies evolve, they are expected to attract more investment and research, potentially leading to a market valuation of 5.6 USD Billion by 2035. The continuous evolution of these devices indicates a promising future for patients requiring mechanical circulatory support.

    Market Segment Insights

    Heart Pump Devices Product Insights

    The Heart Pump Devices Market segmentation, based on product includes Ventricular assist devices, Left ventricular assist devices, Right ventricular assist devices, Bi- ventricular assist devices, Percutaneous ventricular assist devices, Transcutaneous ventricular assist devices, Intra-Aortic balloon pumps, Total artificial heart. During the projected period, it is anticipated that demand for left ventricular assist devices will increase quickly. The dependence on ventricular assist devices for the treatment of heart failure and technological improvements to boost the safety of these devices are credited with the growth.  

    Heart Pump Devices Device Type Insights

    The Heart Pump Devices Market segmentation, based on device type, includes Implantable heart pump devices, and Extracorporeal heart pump devices. During the projected period, the implantable heart pump devices sector is anticipated to develop at the greatest CAGR. The development of implantable heart devices through technology, which has increased their reliability and safety, is credited with the expansion of this market. Due to technical developments, these gadgets are now far more efficient. Patients who are not candidates for heart transplant surgery can use these devices over the long term as a means of survival.  

    Heart Pump Devices Therapy Insights

    The Heart Pump Devices Market segmentation, based on therapy, includes Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination therapy (DT), and Others. Due to an increase in lung and heart transplants, the bridge-to-transplant (BTC) sector experienced the fastest growth rate in the market for heart pump devices. Nearly 70,000 adult lung transplants have been registered since the International Thoracic Organ Transplant (TTX) was founded, and each one has given a recipient with an end-stage lung disease the chance to regain quality of life and longevity, according to data on transplant procedures compiled by the International Society for Heart and Lung Transplantation (ISHLT).

    Heart Pump Devices End-User Insights

    The Heart Pump Devices Market segmentation, based on end-user, includes Hospitals & Clinics, Ambulatory surgical centers, Research institutes, and Others. The largest share belonged to the hospitals & clinics segment. This is explained by the increase in hospital patient visits brought on by the increased prevalence of cardiovascular disorders. The easy availability of payment for such treatments, which helps to lessen the financial strain on patients, is another factor contributing to the rise in the number of cardiac assist device implants. For instance, according to a survey, over 7.7 million people in the UK suffer from circulatory system illnesses.

    Figure 1 Heart Pump Devices Market, by End-User, 2022 & 2032 (USD Billion)

    Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

    Get more detailed insights about Heart Pump Devices Market Research Report – Forecast to 2034

    Regional Insights

    By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Heart Pump Devices Market area will dominate this market. Due to the rising percentage of people suffering from heart strokes and diseases, the region is one of the leading manufacturers and consumers in this industry.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2  HEART PUMP DEVICES MARKET SHARE BY REGION 2022 (USD Billion)HEART PUMP DEVICES MARKET SHARE BY REGION

    Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

    Europe’s Heart Pump Devices Market accounts for the second-largest position in the market due to the increasing technological development across mechanical circulatory care. Further, the German Heart Pump Devices Market held the largest market share, and the UK Heart Pump Devices Market was the quickest-growing market in the European region

    The Asia Pacific Heart Pump Devices Market is anticipated to expand at the quickest CAGR. This is due to the rising awareness established via product developments and research centers programs. Moreover, China Heart Pump Devices Market held the fastest CAGR, and the India Heart Pump Devices Market was the quickest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing largely in research and development to grow their product/service lines, which will aid the Heart Pump Devices Market, to grow even faster. Market leaders are also adopting a variety of strategies to expand their worldwide position, with important market developments including new product launches & developments, contractual agreements among companies with complementary service lines, mergers & acquisitions, higher investments, & collaboration with other organizations having complementary products and services. To grow in a competitive and rising market climate, the Heart Pump Devices industry needs to offer cost-efficient products.

    Producing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Heart Pump Devices industry to benefit clients and increase the market sector. In recent years, the Heart Pump Devices industry has offered some of the most significant advantages to medicine. Major players in the Heart Pump Devices Market, including Medtronic, Abbott Laboratories, Abiomed, Getinge, Syncardia Systems, Teleflex, Reliantheart, Terumo, Berlin Heart, Jarvik Heart, Cardiacassist, Fresenius Medical Care, Thoratec Corporation, and others are attempting to increase market growth via investing in research and development operations.

    A wide variety of healthcare goods are discovered, developed, produced, and sold by Abbott Laboratories (Abbott), including branded generic medications, diagnostic tools and procedures, and infant, child, and adult nutritional supplements. The business also sells a range of medical devices, such as those for neuromodulation, electrophysiology, rhythm control, vascular and structural cardiac devices, and heart failure. The business also sells dietary supplements, minerals, and nutrition goods. It runs manufacturing sites all around the world and has research and development centers in the US, China, Colombia, India, Singapore, Spain, and the UK.

    The corporation sells its goods across Africa, the Middle East, Latin America, North America, and the Asia-Pacific region. In August 2023, According to recently released data from Abbott, the HeartMate 3TM heart pump improves patients' lives by at least five years and represents a definite life-saving alternative for those dealing with severe disease.

    For the treatment of severe heart failure, Jarvik Heart creates miniature heart assist devices. The Jarvik 2000 Ventricular Assist Device, a popular heart pump made by Jarvik Heart, has received CE Mark approval in Europe for both bridge-to-transplant and lifetime use. The PMDA in Japan has given the Jarvik 2000 permission to be used as a bridge to transplant. The Jarvik 2000 is a research device that offers patients lifetime support in the United States. There have been more than 1000 Jarvik 2000 implants performed ly.

    Patients in need of organ transplants as well as those who choose to utilize the Jarvik 2000 for the rest of their lives have had sustained and enhanced health thanks to it. In February 2019, At the National Research Centre for Cardiac Surgery in Astana, Kazakhstan, a ground-breaking medical innovation was made public. Top heart failure specialists from across the world revealed the successful implantation of a FIVAD (Fully Implanted Ventricular Assist Device) into a human at a news conference held at the Centre.

    Key Companies in the Heart Pump Devices Market market include

    Industry Developments

    December 2022 Abiomed declares The two first patients are enrolled in the Impella ECP Pivotal Trial, which has already received FDA approval for the type of Impella ECP that will be utilized. The operations were directed by Amir Kaki, MD, head of mechanical circulatory support at Ascension St. John Hospital in Detroit.

    January 2022 The world's most cutting-edge artificial heart, or Left Ventricular Assist Device (LVAD), is being developed, according to the School of Medical Research and Technology (SMRT), IIT-Kanpur.

    Future Outlook

    Heart Pump Devices Market Future Outlook

    The Global Heart Pump Devices Market is projected to grow at a 21.50% CAGR from 2024 to 2034, driven by technological advancements, increasing cardiovascular diseases, and rising geriatric population.

    New opportunities lie in:

    • Develop innovative miniaturized heart pump devices for outpatient settings.
    • Leverage AI for predictive analytics in patient monitoring and device management.
    • Expand into emerging markets with tailored heart pump solutions.

    By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in cardiovascular treatment solutions.

    Market Segmentation

    Heart Pump Devices Regional Outlook

    • US
    • Canada

    Heart Pump Devices Product Outlook 

    • Ventricular assist devices
    • Left ventricular assist devices
    • Right ventricular assist devices
    • Bi- ventricular assist devices
    • Percutaneous ventricular assist devices
    • Transcutaneous ventricular assist devices
    • Intra-Aortic balloon pumps
    • Total artificial heart

    Heart Pump Devices Therapy Outlook 

    • Bridge-to-candidacy (BTC)
    • Bridge-to-transplant (BTC)
    • Destination therapy (DT)
    • Others

    Heart Pump Devices End-user Outlook 

    • Hospitals & Clinics
    • Ambulatory surgical centers
    • Research institutes
    • Others

    Heart Pump Devices, Device type Outlook 

    • Implantable heart pump devices
    • Extracorporeal heart pump devices

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    0.74 (USD Billion)
    Market Size 2025    0.90 (USD Billion)
    Market Size 2035 6.31 (USD Billion)
    Compound Annual Growth Rate (CAGR) 21.50% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Device Type, Therapy, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Medtronic, Abbott Laboratories, Abiomed, Getinge, Syncardia Systems, Teleflex, Reliantheart
    Key Market Opportunities Growing technological updates across the medical industry
    Key Market Dynamics Increasing number of heart diseases and strokes among the population

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Heart Pump Devices market?

    The Heart Pump Devices market is the expected increase in total market value of 6.31 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Heart Pump Devices market?

    Heart Pump Devices market size was valued at approximately 0.74 billion USD in 2024. This figure will reach 6.31 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Heart Pump Devices market?

    Heart Pump Devices market is expected to grow at a CAGR of 21.5% between 2025 and 2035.

    How much will the Heart Pump Devices market be worth by 2035?

    Heart Pump Devices market is expected to be worth of 6.31 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Heart Pump Devices market perform over the next 10 years?

    Over the next 10 years the Heart Pump Devices market is expected to shift from usd billion 0.74 to 6.31 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the Heart Pump Devices Market?

    North America had the largest share of the market

    1. Table Of Content
    2. Report Prologue
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
      7. Disease Prevalence And Diagnosis Analysis, By Country
    6. Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power Of Suppliers
        2. Bargaining Power Of Buyers
        3. Threat Of New Entrants
        4. Threat Of Substitutes
        5. Intensity Of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Global Heart Pump Devices Market, By Product
      1. Introduction
      2. Ventricular Assist Devices
    8. • Market Estimates & Forecast, 2023-2032
    9. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Left Ventricular Assist Devices
        1. Right Ventricular Assist Devices
        2. Bi-Ventricular Assist Devices
        3. Percutaneous Ventricular Assist Devices
    10. • Market Estimates & Forecast, 2023-2032
      1. Transcutaneous Ventricular Assist Devices
    11. • Market Estimates & Forecast, 2023-2032
    12. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Intra-Aortic Balloon Pumps
      2. Total Artificial Heart
    13. Global Heart Pump Devices Market, By Device Type
      1. Introduction
      2. Implantable Heart Pump Devices
      3. Extracorporeal Heart Pump Devices
    14. Global Heart Pump Devices Market, By Therapy
      1. Introduction
      2. Bridge-To-Candidacy
    15. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Bridge-To-Transplant
    16. • Market Estimates & Forecast, 2023-2032
    17. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Destination Therapy
    18. • Market Estimates & Forecast, 2023-2032
      1. Others
    19. •
    20. Global Heart Pump Devices Market, By End-User
      1. Introduction
      2. Hospitals & Clinics
      3. Ambulatory Surgical Centers
      4. Research Institutes
    21. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Others
    22. Global Heart Pump Devices Market, By Region
      1. Introduction
      2. Americas
    23. • Market Estimates & Forecast, By Region, 2023-2032
    24. • Market Estimates & Forecast, By Product, 2023-2032
    25. • Market Estimates & Forecast, By Type, 2023-2032
    26. • Market Estimates & Forecast, By Therapy, 2023-2032
    27. • Market Estimates & Forecast, By End-User, 2023-2032
      1. North America
    28. • Market Estimates & Forecast, By Country, 2023-2032
    29. • Market Estimates & Forecast, By Product, 2023-2032
    30. • Market Estimates & Forecast, By Type, 2023-2032
    31. • Market Estimates & Forecast, By End-User, 2023-2032
      1. U.S.
    32. • Market Estimates & Forecast, By Product, 2023-2032
    33. • Market Estimates & Forecast, By Type, 2023-2032
    34. • Market Estimates & Forecast, By Therapy, 2023-2032
    35. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Canada
        1. South America
    36. • Market Estimates & Forecast, By Product, 2023-2032
    37. • Market Estimates & Forecast, By Type, 2023-2032
    38. • Market Estimates & Forecast, By Therapy, 2023-2032
    39. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Europe
    40. • Market Estimates & Forecast, By Region, 2023-2032
    41. • Market Estimates & Forecast, By Therapy, 2023-2032
    42. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Western Europe
    43. • Market Estimates & Forecast, By Country, 2023-2032
      1. Germany
        1. France
    44. • Market Estimates & Forecast, By Product, 2023-2032
    45. • Market Estimates & Forecast, By Therapy, 2023-2032
    46. • Market Estimates & Forecast, By End-User, 2023-2032
      1. U.K.
        1. Italy
        2. Eastern Europe
    47. • Market Estimates & Forecast, By Product, 2023-2032
    48. • Market Estimates & Forecast, By Type, 2023-2032
      1. Asia Pacific
    49. • Market Estimates & Forecast, By Country, 2023-2032
      1. Japan
        1. China
        2. India
        3. Australia
        4. Republic Of Korea
        5. Rest Of Asia Pacific
      2. The Middle East & Africa
    50. • Market Estimates & Forecast, By Region, 2023-2032
      1. United Arab Emirates
        1. Saudi Arabia
    51. • Market Estimates & Forecast, By Type, 2023-2032
    52. • Market Estimates & Forecast, By Therapy, 2023-2032
    53. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Oman
        1. Kuwait
        2. Qatar
        3. Rest Of The Middle East & Africa
    54. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    55. Company Profiles
      1. Abbott Laboratories
        1. Company Overview
        2. Product Overview
        3. Financials
        4. SWOT Analysis
      2. Abiomed
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Medtronic
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Getinge
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. Syncardia Systems
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
      6. Teleflex
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
      7. Reliantheart
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Terumo
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Berlin Heart
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      10. Jarvik Heart
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      11. Cardiacassist
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      12. Fresenius Medical Care
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      13. Thoratec Corporation
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      14. HeartWare
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      15. MAQUET GmbH & Co
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
    56. Appendix
    57. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Heart Pump Devices Industry Synopsis, 2023-2032
      3. Table 2 Global Heart Pump Devices Market Estimates And Forecast, 2023-2032, (USD Million)
      4. Table 3 Global Heart Pump Devices Market, By Region, 2023-2032, (USD Million)
      5. Table 5 Global Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      6. Table 5 Global Heart Pump Devices Market, By Product, 2023-2032, (USD Million)
      7. Table 6 Global Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      8. Table 7 Global Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      9. Table 8 North America Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      10. Table 9 North America Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      11. Table 9 North America Heart Pump Devices Market, By Product, 2023-2032, (USD Million)
      12. Table 10 North America Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      13. Table 11 U.S. Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      14. Table 12 U.S. Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      15. Table 12 U.S. Heart Pump Devices Market, By Product, 2023-2032, (USD Million)
      16. Table 13 U.S. Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      17. Table 14 Canada Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      18. Table 14 Canada Heart Pump Devices Market, By Product, 2023-2032, (USD Million)
      19. Table 15 Canada Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      20. Table 16 Canada Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      21. Table 17 South America Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      22. Table 18 South America Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      23. Table 19 South America Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      24. Table 20 Europe Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      25. Table 21 Europe Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      26. Table 22 Europe Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      27. Table 23 Western Europe Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      28. Table 24 Western Europe Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      29. Table 25 Western Europe Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      30. Table 26 Eastern Europe Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      31. Table 27 Eastern Europe Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      32. Table 28 Eastern Europe Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      33. Table 29 Asia Pacific Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      34. Table 30 Asia Pacific Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      35. Table 31 Asia Pacific Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      36. Table 32 Middle East & Africa Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      37. Table 33 Middle East & Africa Heart Pump Devices Market, By Diagnoses, 2023-2032, (USD Million)
      38. Table 34 Middle East & Africa Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)   LIST OF FIGURES
      39. Figure 1 Research Process
      40. Figure 2 Segmentation For Global Heart Pump Devices Market
      41. Figure 3 Segmentation Market Dynamics For Heart Pump Devices Market
      42. Figure 4 Global Heart Pump Devices Market Share, By Type 2020
      43. Figure 5 Global Heart Pump Devices Market Share, By Product 2020
      44. Figure 6 Global Heart Pump Devices Market Share, By End-Users, 2020
      45. Figure 7 Global Heart Pump Devices Market Share, By Region, 2020
      46. Figure 8 North America Heart Pump Devices Market Share, By Country, 2020
      47. Figure 9 Europe Heart Pump Devices Market Share, By Country, 2020
      48. Figure 10 Asia Pacific Heart Pump Devices Market Share, By Country, 2020
      49. Figure 11 Middle East & Africa Heart Pump Devices Market Share, By Country, 2020
      50. Figure 12 Global Heart Pump Devices Market: Company Share Analysis, 2020 (%)
      51. Figure 13 Abbott Laboratories: Key Financials
      52. Figure 14 Abbott Laboratories: Segmental Revenue
      53. Figure 16 Abbott Laboratories: Geographical Revenue
      54. Figure 17 Medtronic. Key Financials
      55. Figure 18 Medtronic: Segmental Revenue
      56. Figure 19 Medtronic: Geographical Revenue
      57. Figure 20 Terumo: Key Financials
      58. Figure 21 Terumo: Segmental Revenue
      59. Figure 22 Terumo: Geographical Revenue
      60. Figure 23 Getinge: Key Financials
      61. Figure 24 Getinge: Segmental Revenue
      62. Figure 25 Getinge: Geographical Revenue
      63. Figure 26 Teleflex: Key Financials
      64. Figure 27 Teleflex: Segmental Revenue
      65. Figure 28 Teleflex. Geographical Revenue
      66. Figure 29 Abiomed. Key Financials
      67. Figure 30 Abiomed. Segmental Revenue
      68. Figure 31 Abiomed. Geographical Revenue
      69. Figure 32 Cardiacassist. Key Financials
      70. Figure 33 Cardiacassist. Segmental Revenue
      71. Figure 34 Cardiacassist. Geographical Revenue

    Heart Pump Devices Market Segmentation

    Heart Pump Devices Product Outlook (USD Billion, 2018-2032)

    • Ventricular assist devices
    • Left ventricular assist devices
    • Right ventricular assist devices
    • Bi- ventricular assist devices
    • Percutaneous ventricular assist devices
    • Transcutaneous ventricular assist devices
    • Intra-Aortic balloon pumps
    • Total artificial heart

    Heart Pump Devices, Device type Outlook (USD Billion, 2018-2032)

    • Implantable heart pump devices
    • Extracorporeal heart pump devices

    Heart Pump Devices Therapy Outlook (USD Billion, 2018-2032)

    • Bridge-to-candidacy (BTC)
    • Bridge-to-transplant (BTC)
    • Destination therapy (DT)
    • Others

    Heart Pump Devices End-user Outlook (USD Billion, 2018-2032)

    • Hospitals & Clinics
    • Ambulatory surgical centers
    • Research institutes
    • Others

    Heart Pump Devices Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • North America Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • North America Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • North America Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • North America Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • US Outlook (USD Billion, 2018-2032)

      • US Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • US Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • US Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • US Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • CANADA Outlook (USD Billion, 2018-2032)

      • CANADA Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • CANADA Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • CANADA Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • CANADA Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

    • Europe Outlook (USD Billion, 2018-2032)

      • Europe Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Europe Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Europe Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • Europe Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Germany Outlook (USD Billion, 2018-2032)

      • Germany Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Germany Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Germany Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • Germany Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • France Outlook (USD Billion, 2018-2032)

      • France Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • France Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • France Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • France Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • UK Outlook (USD Billion, 2018-2032)

      • UK Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • UK Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • UK Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • UK Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • ITALY Outlook (USD Billion, 2018-2032)

      • ITALY Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • ITALY Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • ITALY Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • ITALY Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • SPAIN Outlook (USD Billion, 2018-2032)

      • Spain Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Spain Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Spain Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Spain Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Rest Of Europe Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • REST OF EUROPE Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • REST OF EUROPE Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • REST OF EUROPE Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Asia-Pacific Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Asia-Pacific Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Asia-Pacific Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Asia-Pacific Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • China Outlook (USD Billion, 2018-2032)

      • China Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • China Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • China Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • China Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Japan Outlook (USD Billion, 2018-2032)

      • Japan Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Japan Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Japan Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Japan Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • India Outlook (USD Billion, 2018-2032)

      • India Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • India Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • India Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • India Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Australia Outlook (USD Billion, 2018-2032)

      • Australia Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Australia Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Australia Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Australia Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Rest of Asia-Pacific Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Rest of Asia-Pacific Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Rest of Asia-Pacific Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Rest of Asia-Pacific Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Rest of the World Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Rest of the World Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Rest of the World Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Rest of the World Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Middle East Outlook (USD Billion, 2018-2032)

      • Middle East Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Middle East Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Middle East Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Middle East Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Africa Outlook (USD Billion, 2018-2032)

      • Africa Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Africa Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Africa Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Africa Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Latin America Outlook (USD Billion, 2018-2032)

      • Latin America Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Latin America Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Latin America Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Latin America Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027